fda warning letters compounded semaglutide september 2025 Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP-1 compounding while @martymakary is photographed holding bootleg # FDA issued 25 warning letters

Using the French national health database, the authors compared 2,562 people with thyroid cancer against more than 45,000 matched controls

These medications are expensive, demand is high, and federal healthcare programs, including TRICARE, are managing access rather than expanding it without limits

He was beyond annoyed

The study also found that non-invasive blood tests and imaging measures reflected treatment-related improvements more clearly than liver biopsies

All three medicationsZepbound, Wegovy, and Ozempicwork by influencing the bodys appetite and metabolism through the GLP-1 (glucagon-like peptide-1) pathway

Conclusion: GLP-1 RAs may aid preconception metabolic optimization